Cargando…

CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens

The CEA family comprises 18 genes and 11 pseudogenes located at chromosome 19q13.2 and is divided into two main groups: cell surface anchored CEA-related cell adhesion molecules (CEACAMs) and the secreted pregnancy-specific glycoproteins (PSGs). CEACAMs are highly glycosylated cell surface anchored,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Jerin, Klebanov, Addison, John, Sahara, Miller, Larry S., Vegesna, Anil, Amdur, Richard L., Bhowmick, Krishanu, Mishra, Lopa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891707/ https://www.ncbi.nlm.nih.gov/pubmed/36741860 http://dx.doi.org/10.18632/genesandcancer.230

Ejemplares similares

Interactions of pathogenic Escherichia coli with CEACAMs
por: Sheikh, Alaullah, et al.
Publicado: (2023)

Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers
por: Blumenthal, Rosalyn D, et al.
Publicado: (2007)

T cell-mediated elimination of cancer cells by blocking CEACAM6–CEACAM1 interaction
por: Pinkert, Jessica, et al.
Publicado: (2021)

Recent advances in the tumour biology of the GPI-anchored carcinoembryonic antigen family members CEACAM5 and CEACAM6
por: Chan, C.H.F., et al.
Publicado: (2007)

Soluble CEACAM8 Interacts with CEACAM1 Inhibiting TLR2-Triggered Immune Responses
por: Singer, Bernhard B., et al.
Publicado: (2014)

Heterogeneity of CEACAM5 in breast cancer
por: Bechmann, Marc B., et al.
Publicado: (2020)

CEACAM1 recognition by bacterial pathogens is species-specific
por: Voges, Maike, et al.
Publicado: (2010)

CEACAM6 gene expression in intrahepatic cholangiocarcinoma
por: Ieta, K, et al.
Publicado: (2006)

CEACAM6 Gene Variants in Inflammatory Bowel Disease
por: Glas, Jürgen, et al.
Publicado: (2011)

Binding of Candida albicans to Human CEACAM1 and CEACAM6 Modulates the Inflammatory Response of Intestinal Epithelial Cells
por: Klaile, Esther, et al.
Publicado: (2017)

Role of CEACAM1 and CEACAM20 in an In Vitro Model of Prostate Morphogenesis
por: Zhang, Hui, et al.
Publicado: (2013)

Carcinoembryonic Antigen-Related Cell Adhesion Molecules (CEACAM) 1, 5 and 6 as Biomarkers in Pancreatic Cancer
por: Gebauer, Florian, et al.
Publicado: (2014)

CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness
por: Duxbury, M S, et al.
Publicado: (2004)

TIM‐3 and CEACAM1 do not interact in cis and in trans
por: De Sousa Linhares, Annika, et al.
Publicado: (2020)

Characterizing CEACAM5 interaction with CD8α and CD1d in intestinal homeostasis
por: Roda, G, et al.
Publicado: (2013)

Signaling by epithelial members of the CEACAM family – mucosal docking sites for pathogenic bacteria
por: Tchoupa, Arnaud Kengmo, et al.
Publicado: (2014)

CEACAM6’s Role as a Chemoresistance and Prognostic Biomarker for Pancreatic Cancer: A Comparison of CEACAM6’s Diagnostic and Prognostic Capabilities with Those of CA19-9 and CEA
por: Kurlinkus, Benediktas, et al.
Publicado: (2021)

CEACAMs: their role in physiology and pathophysiology
por: Kuespert, Katharina, et al.
Publicado: (2006)

CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma
por: Wang, Xueying, et al.
Publicado: (2022)

Overexpression of CEACAM6 activates Src-FAK signaling and inhibits anoikis, through homophilic interactions in lung adenocarcinomas
por: Kim, Eun Young, et al.
Publicado: (2022)

Structural analysis of human CEACAM1 oligomerization
por: Gandhi, Amit K., et al.
Publicado: (2022)

CEACAM expression in an in-vitro prostatitis model
por: Kube-Golovin, Irina, et al.
Publicado: (2023)

CEACAM6 is a prognostic biomarker and potential therapeutic target for gastric carcinoma
por: Ru, Guo-Qing, et al.
Publicado: (2017)

Effect of CEACAM6 silencing on the biological behavior of human gallbladder cancer cells
por: Tian, Chengming, et al.
Publicado: (2020)

Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis
por: Burgos, Miguel, et al.
Publicado: (2022)

CEACAM6: A Novel Marker of Chronic Obstructive Pulmonary Disease Susceptibility?
por: Racanelli, Alexandra C., et al.
Publicado: (2023)

MicroRNA 29a therapy for CEACAM6-expressing lung adenocarcinoma
por: Son, Seung-Myoung, et al.
Publicado: (2023)

CEACAM1-Mediated Inhibition of Virus Production
por: Vitenshtein, Alon, et al.
Publicado: (2016)

Homophilic adhesion and CEACAM1-S regulate dimerization of CEACAM1-L and recruitment of SHP-2 and c-Src
por: Müller, Mario M., et al.
Publicado: (2009)

CEACAM 1, 3, 5 and 6 -positive classical monocytes correlate with interstitial lung disease in early systemic sclerosis
por: Yokoyama, Kana, et al.
Publicado: (2022)

Reversal of obesity development in Ceacam1 ( −/− ) male mice by bone marrow transplantation or introduction of the human CEACAM1 gene
por: Zhang, Zhifang, et al.
Publicado: (2022)

FOXP3 and CEACAM6 expression and T cell infiltration in the occurrence and development of colon cancer
por: LIU, YINGYING, et al.
Publicado: (2016)

CEACAM6 is associated with osteosarcoma metastasis and facilitates epithelial–mesenchymal transition in osteosarcoma cells
por: Wang, Zeyu, et al.
Publicado: (2018)

Therapeutic Effect of pHLIP-mediated CEACAM6 Gene Silencing in Lung Adenocarcinoma
por: Son, Seung-Myoung, et al.
Publicado: (2019)

CEACAM1: Expression and Role in Melanocyte Transformation
por: Turcu, Gabriela, et al.
Publicado: (2016)

CEACAM1 promotes vascular aging processes
por: Kleefeldt, Florian, et al.
Publicado: (2020)

The CEACAM1 N-terminal Ig domain mediates cis- and trans-binding and is essential for allosteric rearrangements of CEACAM1 microclusters
por: Klaile, Esther, et al.
Publicado: (2009)

Liver-specific rescuing of CEACAM1 reverses endothelial and cardiovascular abnormalities in male mice with null deletion of Ceacam1 gene
por: Russo, Lucia, et al.
Publicado: (2018)

CEACAM engagement by human pathogens enhances cell adhesion and counteracts bacteria-induced detachment of epithelial cells
por: Muenzner, Petra, et al.
Publicado: (2005)

CEACAM1 as a multi-purpose target for cancer immunotherapy
por: Dankner, Matthew, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4uj31ivkd2k3ul1e6t3qgvdep1